Dendritic cells (DCs) can influence HIV-1 and SIV pathogenesis and protective mechanisms
at several levels. First, HIV-1 productively infects select populations of DCs in culture …

The immunotherapy of cancer is predicated on the belief that it is possible to generate a
clinically meaningful antitumor response that provides patient benefit, such as improvement …

Vaccinia virus employs multiple mechanisms to evade the immune system, yet is highly
immunogenic. We studied the interaction between vaccinia and human dendritic cells (DCs) …

The Epstein-Barr virus (EBV)-encoded nuclear antigen EBNA1 is critical for the persistence
of the viral episome in replicating EBV-transformed human B cells. Therefore, all EBV …

Dendritic cells (DC) are the major APCs involved in naive T cell activation making them
prime targets of vaccine research. We observed that mRNA was efficiently transfected …

Dendritic cells (DCs) genetically modified to continually express and present antigens may
be potent physiologic adjuvants for induction of prophylactic or therapeutic immunity. We …

Dendritic cells (DCs) are professional antigen-presenting cells that are highly effective
adjuvants for immunizing against pathogens and tumor antigens. The potential merit of …

Dendritic cells (DC) are potent antigen-presenting cells (APC). Ongoing preclinical and
clinical studies exploit this capacity for the immunotherapy of tumors. We tested vaccinia …

Epstein‐Barr virus (EBV) is associated with various malignancies and infects> 90% of the
global population. EBV latent proteins are expressed in numerous EBV‐associated cancers …

A novel coronavirus, severe acute respiratory syndrome (SARS)–associated coronavirus
(SARS-CoV), has been identified as the causal agent of SARS. Spike (S) protein is a major …